no statistically significant association was observed with all-cause mortality (rr, 0.96; 95% ci, 0.91 to 1.02; risk reduction [rd] -0.004, 95% ci, -0.01 to 0.02), cardiac death (rr, 0.91; 95% ci, 0.85 to 0.98; rd, -0.01; 95% ci, -0.02 to 0.00), sudden death (rr, 0.87; 95% ci, 0.75 to 1.01; rd, -0.003; 95% ci, -0.012 to 0.006), myocardial infarction (rr, 0.89; 95% ci, 0.76 to 1.04; rd, -0.002; 95% ci, -0.007 to 0.002), and stroke (rr, 1.05; 95% ci, 0.93 to 1.18; rd, 0.001; 95% ci, -0.002 to 0.004) when all supplement studies were considered.